Beyond Survival: How to Manage Cancer Smarter

Every June, National Cancer SurvivorsMonth reminds us to recognize the strength, resilience, and ongoing needs ofpeople living with and beyond cancer.

Cancer survivorship is not defined by asingle moment. It begins at diagnosis and continues throughout a person’s life.For many patients, survivorship includes active treatment, follow-up care,long-term monitoring, emotional adjustment, and ongoing decisions about how tomanage health after cancer.

What is cancer management?

Cancer management is the ongoing process of understanding, treating, monitoring, and making care decisions throughout the cancer journey. It may include diagnosis, biomarker testing, treatment planning, response evaluation, recurrence monitoring, and long-term survivorship care.

A cancer diagnosis often begins with many urgent questions.

What type of cancer is it?
How aggressive is it?
Which treatment options are most appropriate?
Is targeted therapy or immunotherapy suitable?
How should the disease be monitored over time?

Traditionally, cancer treatment decisions were largely guided by cancertype, tumor location, stage, and pathology. These remain essential. However,cancers that look similar under a microscope may behave differently at themolecular level.

Cancer genomic testing can help reveal the genetic alterations driving a tumor. By understanding these molecular features, clinicians may gainadditional information to support diagnosis, treatment planning, considerationof clinical trials, and monitoring.

Whygenomic insights matter across the cancer journey

For cancer survivors, genomic information may be relevant atdifferent points in the care journey. At diagnosis, cancer genomic testing may help clarify molecularsubtype and identify potential treatment options.

During treatment, molecular findings may inform decisions about targeted therapy, immunotherapy, or participation in a clinical trial.

If cancer progresses or recurs, genomic information may helpclinicians reassess treatment options, identify potential resistancemechanisms, or determine whether additional testing is appropriate.

After treatment, monitoring becomes a central part of long-termcancer management. Survivorship care often includes regular follow-up visits,imaging, laboratory tests, and clinical evaluation to watch for recurrence,treatment response, disease progression, or long-term side effects.

In selected clinical situations, molecular tools may provideadditional information to help clinicians better understand recurrence risk,detect disease-related changes, or support future management decisions. As cancercare continues to evolve, monitoring is not only about looking for whethercancer has returned; it is also about using the right information over time toguide the next step in care.

In this sense, precision medicine is not only about choosing thefirst treatment. It is about building a more informed cancer managementstrategy that includes treatment selection, monitoring, follow-up, andlong-term care.

What role does monitoring play in long-term cancer care?

Monitoring is one of the most important parts of survivorship careand long-term cancer management. After diagnosis and treatment, patients may continue to need regular follow-up to evaluate treatment response, detect recurrence, manage side effects, and guide future care decisions.

For some patients, monitoring may involve imaging, blood tests,clinical examination, or other assessments recommended by the healthcare team.In selected situations, molecular information may also support a morepersonalized understanding of disease behavior over time.

The purpose of monitoring is not only to assess whether treatmentworked, but also to help clinicians and patients plan ahead with greater clarity.

Why survivorshipneeds precision

Every cancer survivor’s journey is different. Some people continue treatment for years. Some live with the possibility of recurrence. Some facelong-term side effects, emotional stress, or uncertainty about the future.Others must decide on family risk, additional testing, or future care planning.

A more precise understanding of each patient’s cancer can help makethese conversations more personalized.

For clinicians, genomic insights may provide additional information to support treatment planning, monitoring, and follow-up strategies. Forpatients and families, these insights may help turn uncertainty into clearerquestions, more informed discussions, and a stronger sense of direction.

Cancer survivorship is not just about surviving cancer. It is aboutliving with the best possible care plan, supported by the right information atthe right time.

ACTGenomics: supporting precision cancer management

At ACT Genomics, we believe that better cancer management beginswith better molecular insight.

Through NGS-based cancer genomic testing, ACT Genomics supports cliniciansin identifying clinically relevant genomic alterations that may informprecision medicine strategies. By integrating genomic data with clinicalcontext, we aim to help medical teams and patients navigate cancer care withgreater clarity.

Disclaimer

This content is provided for informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Any testing ortreatment decisions should be made by qualified healthcare professionals basedon each patient’s individual condition and the latest clinical evidence.

References

1. National Cancer Institute. Cancer Survivorship: https://www.cancer.gov/about-cancer/coping/survivorship
2. National Cancer InstituteOffice of Cancer Survivorship. National Cancer SurvivorsMonth: https://cancercontrol.cancer.gov/ocs/about/survivorship-month
3. National Cancer Institute. Biomarker Testing for Cancer Treatment: https://www.cancer.gov/about-cancer/treatment/types/biomarker-testing-cancer-treatment
4. National Cancer Institute. Cancer Genome Research and Precision Medicine: https://www.cancer.gov/ccg/research/cancer-genomics-overview
5. American Cancer Society. Precision or Personalized Medicine: https://www.cancer.org/cancer/managing-cancer/treatment-types/precision-medicine.html
6. National Cancer InstituteDictionary of Cancer Terms. Definition of biomarkertesting: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biomarker-testing
7. National CancerInstitute Office of Cancer Survivorship. National Standards for CancerSurvivorship Care: https://cancercontrol.cancer.gov/ocs/special-focus-areas/national-standards-cancer-survivorship-care